Suzuken Co., Ltd. (FRA:ZU1)

Market Cap	1.85B -22.8%
Revenue (ttm)	13.58B +4.7%
Net Income	203.20M +13.3%
EPS	2.95 +22.5%
Shares Out	n/a
PE Ratio	9.11
Forward PE	n/a
Dividend	0.59 (2.20%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	27.00
Previous Close	26.80
Day's Range	27.00 - 27.00
52-Week Range	25.60 - 35.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medica...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1932
• Employees: 12,717
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ZU1

Financial Performance

In fiscal year 2026, Suzuken's revenue was 2.49 trillion, an increase of 3.61% compared to the previous year's 2.40 trillion. Earnings were 38.14 billion, an increase of 10.55%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error